Skip to main content
Log in

Reversible cerebral vasoconstriction syndrome triggered by ondansetron

  • Neuro-Images
  • Published:
Acta Neurologica Belgica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Ducros A (2012) Reversible cerebral vasoconstriction syndrome. Lancet Neurol 11:906–917. https://doi.org/10.1016/S1474-4422(12)70135-7

    Article  PubMed  Google Scholar 

  2. Rocha E, Topcuoglu M, Silva G, Singhal A (2019) RCVS2 score and diagnostic approach for reversible cerebral vasoconstriction syndrome. Neurology 92:639–647. https://doi.org/10.1212/WNL.0000000000006917

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Laetitia della Faille.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

della Faille, L., Claesen, E., Cappelle, S. et al. Reversible cerebral vasoconstriction syndrome triggered by ondansetron. Acta Neurol Belg 121, 1061–1063 (2021). https://doi.org/10.1007/s13760-021-01678-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13760-021-01678-2

Keywords

Navigation